1. Introduction {#sec1-biomolecules-10-00569}
===============

Fungi are potentially known as a promising source of bioactive compounds for drug discovery \[[@B1-biomolecules-10-00569]\]. Mushrooms and other Basidiomycota, in particular, are widely used in traditional Chinese medicines and have been shown to provide beneficial activities against cancer and other ailments \[[@B2-biomolecules-10-00569],[@B3-biomolecules-10-00569]\], but even the microfungi have various other potential benefits \[[@B4-biomolecules-10-00569]\]. Dothideomycetes (Ascomycota) is a large and diverse class comprising of mostly microfungi. New species are constantly being discovered from this group and could be promising sources of novel bioactive compounds \[[@B5-biomolecules-10-00569],[@B6-biomolecules-10-00569],[@B7-biomolecules-10-00569]\]. A few contemporary studies in Thailand have been focusing on saprobic fungi in Dothideomycetes as a source for finding novel bioactive compounds. For example, a novel Thai Dothideomycete, *Pseudobambusicola thailandica*, has yielded six new compounds with nematicidal and antimicrobial activity \[[@B8-biomolecules-10-00569]\]. A new abscisic acid derivative with anti-biofilm activity against *Staphylococcus aureus* was isolated from cultures of a *Roussoella* sp. inhabiting *Clematis subumbellata* in northern Thailand \[[@B9-biomolecules-10-00569]\], while *Sparticola junci*, another new Thai dothideomycete, yielded seven new spirodioxynaphthalenes with antimicrobial and cytotoxic activities \[[@B10-biomolecules-10-00569]\]. Recently some phenalenones from another new Thai *Pseudolophiostoma* species were found to selectively inhibit α-glucosidase and lipase \[[@B11-biomolecules-10-00569]\]. In spite of these recent discoveries, the study of bioactive compounds from Thai and other tropical Dothideomycetes is still in the initial stages of research.

In this study, we provide morphological descriptions and illustrations of a new Dothideomycetes fungus *Pseudopalawania siamensis*, collected from *Caryota* sp. (Arecaceae) in northern Thailand, based on multi-gene analyses and morphological comparison to confirm the current taxonomic placement of the fungus. In addition, we studied the new fungus for the production of bioactive compounds because its extracts showed significant antimicrobial activities in a preliminary screening. Thus, we here report the first secondary metabolites from this species, including their isolation, structure elucidation, and biological activity.

2. Materials and Methods {#sec2-biomolecules-10-00569}
========================

2.1. Sample Collection, Specimen Examination and Isolation of Fungi {#sec2dot1-biomolecules-10-00569}
-------------------------------------------------------------------

Fresh material was collected from Nan Province, Thailand, in 2016. Fungal micromorphology was examined using a Motic, (Hongkong, China) SMZ 168 Series microscope. The appearance of ascomata on substrate was captured using a (stereo microscope fitted with an AxioCam ERC 5S camera (Carl Zeiss GmbH, Jena, Germany). Sections of ascomata were made by free hand. Fungal material was mounted in water and photographed with a Nikon (Bangkok, Thailand) ECLIPSE Ni compound microscope fitted with a Canon (Singapore) EOS 600D digital camera. Fungal photoplate was processed with Adobe Photoshop CS6 version 13.1.2 (Adobe Systems, CA, USA). All microscopic characters were measured using Tarosoft Image Frame Work program (IFW) version 0.97 (Nonthaburi, Thailand). Single spore isolations were obtained using the methods of Chomnunti et al. \[[@B12-biomolecules-10-00569]\]. Germinating ascospores were transferred to a new malt extract agar (MEA) media and incubated at room temperature (25 °C) in the dark. Fungal cultures were used for molecular study and secondary metabolite production. The specimens and living cultures are deposited in the Herbarium of Mae Fah Luang University (Herb. MFLU) and Culture collection Mae Fah Luang University (MFLUCC), Chiang Rai, Thailand. Nomenclature and taxonomic information were deposited in MycoBank \[[@B13-biomolecules-10-00569]\].

2.2. DNA Extraction, PCR Amplification and Sequencing {#sec2dot2-biomolecules-10-00569}
-----------------------------------------------------

The genomic DNA from the fungal mycelium was extracted by using the ZR Soil Microbe DNA MiniPrep kit (Zymo Research, Irvine, CA, USA) following the manufacturer's instructions. DNA amplifications were performed by polymerase chain reaction (PCR). The partial large subunit nuclear rDNA (LSU) was amplified with primer pairs LROR and LR5 \[[@B14-biomolecules-10-00569]\]. The internal transcribed spacer (ITS) was amplified by using primer pairs ITS5 and ITS4 \[[@B15-biomolecules-10-00569]\]. The partial small subunit nuclear rDNA (SSU) was amplified with primer pairs NS1 and NS4 \[[@B15-biomolecules-10-00569]\]. The translation elongation factor 1-alpha gene (TEF1) was amplified by using primers EF1-983F and EF1-2218R \[[@B16-biomolecules-10-00569]\]. The partial gene encoding for the second largest RNA polymerase subunit (RPB2) was amplified by using primers fRPB2-5F and fRPB2- 7cR \[[@B17-biomolecules-10-00569]\]. Methods for PCR amplification and sequencing were carried out according to previously described procedures \[[@B18-biomolecules-10-00569],[@B19-biomolecules-10-00569]\].

2.3. Phylogenetic Analysis {#sec2dot3-biomolecules-10-00569}
--------------------------

The closest matched taxa were determined through nucleotide BLAST searches online in GenBank (<http://www.ncbi.nlm.nih.gov/>). Combined LSU: 28S large subunit of the nrRNA gene; ITS: internal transcribed spacer regions 1 and 2 including 5.8S nrRNA gene; SSU: 18S small subunit of the nrRNA gene; TEF1: partial translation elongation factor 1-α gene; and RPB2: partial RNA polymerase II second largest subunit gene sequence data from representative closest relatives to our strains were selected following Hongsanan et al. \[[@B20-biomolecules-10-00569]\], Crous et al. \[[@B21-biomolecules-10-00569]\], Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\], and Mapook et al. \[[@B23-biomolecules-10-00569],[@B24-biomolecules-10-00569]\], to confirm the phylogenetic placement of our new strains. The phylogenetic analysis based on maximum likelihood (ML) and Bayesian inference (BI) were following the methodology as described in Mapook et al. \[[@B23-biomolecules-10-00569],[@B24-biomolecules-10-00569]\]. The sequences used for analyses with accession numbers are given in [Table 1](#biomolecules-10-00569-t001){ref-type="table"}. Phylogram generated from ML analysis was drawn using FigTree v. 1.4.2 \[[@B25-biomolecules-10-00569]\] and edited by Microsoft Office PowerPoint 2013. The new nucleotide sequence data are deposited in GenBank.

2.4. General Information of Chromatography and Spectral Methods {#sec2dot4-biomolecules-10-00569}
---------------------------------------------------------------

Specific optical rotations (\[α\]~D~) were measured using a Perkin-Elmer (Überlingen, Germany) 241 polarimeter in a 100 × 2 mm cell at 22 °C. ECD spectra were recorded on a J-815 spectropolarimeter (JASCO, Pfungstadt, Germany). UV spectra were obtained on a Shimadzu (Duisburg, Germany) UV-Vis spectrophotometer UV-2450 with 1 cm quartz cells. IR spectra were measured with a Nicolet Spectrum 100 FT-IR spectrometer (Perkin-Elmer, Waltham, MA, USA). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 700 MHz Avance III spectrometer with a 5 mm TXI cryoprobe (^1^H 700 MHz, ^13^C 175 MHz) and a Bruker 500 MHz Avance III spectrometer with a BBFO (plus) SmartProbe (^1^H 500 MHz, ^13^C 125 MHz). In all cases, spectra were acquired at 25 °C (unless otherwise specified) in solvents as specified in the text, with referencing to residual ^1^H or ^13^C signals in the deuterated solvents (CDCl~3~ or MeOH-*d*~4~). HPLC-DAD/MS analysis was conducted using an amaZon Speed ETD ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany). HR-ESI mass spectra was measured using an Agilent 1200 series HPLC-UV system (column 2.1 × 50 mm, 1.7 μm, C18 Waters Acquity UPLC BEH) combined with an maXis (Bruker) ESI-TOF-MS instrument The mobile phase was composed of H~2~O + 0.1% formic acid (solvent A) and acetonitrile + 0.1% formic acid (solvent B), with the following gradient: 5% solvent B for 0.5 min with a flow rate of 0.6 mL/min, increasing to 100% solvent B in 19.5 min and then maintaining 100% solvent B for 5 min. UV/Vis detection at 200--600 nm. Chemicals and solvents were obtained from AppliChem GmbH, Avantor Performance Materials, Carl Roth GmbH & Co. KG (Karlsruhe, Germany) and Merck KGaA (Darmstadt, Germany) in analytical and HPLC grade.

2.5. Fermentation and Extraction {#sec2dot5-biomolecules-10-00569}
--------------------------------

Five mycelial plugs from actively growing colonies on malt extract agar (MEA) media (malt extract 20 g/L, D-glucose 20 g/L, peptone 6 g/L, pH 6.3) were cut using a sterile cork borer (0.7 × 0.7 cm^2^) and placed into a sterilized 500 mL Erlenmeyer flask containing 200 mL of liquid yeast malt (YM) medium (malt extract 10 g/L, D-glucose 4 g/L, yeast extract 4 g/L, pH 6.3). These seed cultures were incubated on a rotary shaker (140 rpm) at 23 °C in the dark for nine days. Ten milliliters of the seed culture were added into 25 × 500 mL sterile Erlenmeyer flasks with 200 mL of YM medium and incubated on a rotary shaker for 14 days. The extraction was conducted 3 days after glucose depletion as monitored by the glucose strip test using Bayer Harnzuckerstreifen, (Bayer, Leverkusen, Germany). Fungal mycelium and supernatant were separated by using vacuum filtration. The supernatant was mixed with 3% Amberlite XAD-16N adsorber resin (Sigma-Aldrich, Deisenhofen, Germany) and stirred for 1 h and filtrated to remove the culture broth. The XAD resin was eluted three times with an equal volume of ethyl acetate. The mycelia were extracted twice with an equal volume of acetone in an ultrasonic bath for 30 min and the combined extracts were passed through a filter, then dissolved in water/ethyl acetate. The aqueous phase (lower) was discarded while the organic phase (upper) was filtered through anhydrous sodium sulfate (Na~2~SO~4~) for water removal and then evaporated to dryness. This procedure yielded 1580 mg mycelial crude extract and 769 mg of supernatant crude extract. The mycelial extract contained mainly fatty acids and ergosterol derivatives and showed only weak bioactivity. It was therefore not further processed. The supernatant extract contained the majority of the active components and was therefore subjected to preparative isolation of its active ingredients.

2.6. Isolation of Compounds ***1***--***5*** {#sec2dot6-biomolecules-10-00569}
--------------------------------------------

The supernatant crude extract was dissolved in methanol and initially fractionated on preparative HPLC manufactured by Gilson (Middleton, Wi, USA), comprised of a GX-271 Liquid Handler, a 172 DAD, a 305 and 306 pump, with 50SC Piston Pump Head. A Phenomenex (Torrance, Ca., USA) Gemini 10u C~18~ 110Å column (250 × 21.20 mm, 10 μm) was used as a stationary phase. The mobile phase was composed of deionised water (Milli-Q, Millipore, Schwalbach, Germany) with 0.05% of trifluoroacetic acid (TFA) as a solvent A and acetonitrile (ACN) HPLC grade with 0.05% TFA as a solvent B. The fractionation proceeded with the following gradient: linear gradient of 10% solvent B for 5 min with a flow rate of 35 mL/min, followed by 10% to 100 % solvent B for 30 min, and 100% solvent B for 10 min. The UV detection was carried out at 210, 254 and 350 nm. Final five compounds were purified from initially 16 fractions ([Figure 1](#biomolecules-10-00569-f001){ref-type="fig"}). Compound **1** (pseudopalawanone; 5.51 mg) eluted at *t*~R~ = 7.8 min from fraction 12, compound **2** (4,4′-secalonic acid D; 5.48 mg) eluted at *t*~R~ = 10.5 min from fraction 15, compound **4** (paecilin B; 1.08 mg) eluted at *t*~R~ = 6.9 min from fraction 4, and compound **5** (cephalanone F; 1.52 mg) eluted at *t*~R~ = 3.0 min from fraction 3, while compound **3** (penicillixanthone A; 0.86 mg) eluted at *t*~R~ = 11.3 min was resulted from the purification of fraction 16 (4.12 mg) on a VarioPrep Nucleodur 100-10 C~18~ ec column (150 *×* 40 mm, 7 µm; Macherey-Nagel, Düren, Germany) using the following gradients: linear gradient of 30% solvent B for 5 min with a flow rate of 15 mL/min, followed by 30% to 100 % solvent B for 20 min, and 100% solvent B for 10 min.

2.7. Spectral Data {#sec2dot7-biomolecules-10-00569}
------------------

### Pseudopalawanone (**1**)

Pale yellowish gum. \[a\]^25^~D~ = +30.0 (*c* 1.0, MeOH). ^1^H NMR (500 MHz, CDCl~3~): see [Table 2](#biomolecules-10-00569-t002){ref-type="table"}; ^13^C NMR (125 MHz, CDCl~3~): see [Table 2](#biomolecules-10-00569-t002){ref-type="table"}. HR-ESIMS *m/z* 641.1492 (\[M + H\]^+^, calcd for C~31~H~29~O~15~, 641.1501).

2.8. Antimicrobial Activity and Cytotoxicity Assays {#sec2dot8-biomolecules-10-00569}
---------------------------------------------------

Minimum inhibitory concentrations (MIC) of compounds **1**--**5** were determined against various fungal and bacterial strains by using a 96-well serial dilution technique according to previously described procedures \[[@B92-biomolecules-10-00569],[@B93-biomolecules-10-00569]\]. The tested organisms with results are given in [Table 3](#biomolecules-10-00569-t003){ref-type="table"} and [Table 4](#biomolecules-10-00569-t004){ref-type="table"}. Gentamicin, kanamycin, nystatin, and oxytetracycline were used as positive controls against tested organisms. In vitro cytotoxicity (IC~50~) of compounds **1**--**5** were determined using the MTT assay according to previously described procedures \[[@B26-biomolecules-10-00569],[@B27-biomolecules-10-00569]\] against the mouse fibroblast cell line (L929) and the human HeLa (KB-3-1) cell line. Epothilone B and methanol were used as positive and negative control, respectively.

3. Results and Discussion {#sec3-biomolecules-10-00569}
=========================

3.1. Phylogenetic Analysis {#sec3dot1-biomolecules-10-00569}
--------------------------

The combined dataset of LSU, SSU, RPB2, ITS and TEF sequence data including our new strains were analyzed by maximum likelihood (ML) and Bayesian analyses. The combined sequence alignment is comprised of 155 taxa (6131 characters with gaps), which include representative strains from Lecanoromycetes as outgroup taxa. A best scoring RAxML tree with a final likelihood value of -91,669.392085 is presented in [Figure 2](#biomolecules-10-00569-f002){ref-type="fig"}. The matrix had 3930 distinct alignment patterns, with 59.36% of undetermined characters or gaps. Estimated base frequencies were as follows: A = 0.242975, C = 0.253394, G = 0.277569, T = 0.226061; substitution rates: AC = 1.292278, AG = 3.020191, AT = 1.589713, CG = 1.197479, CT = 6.661698, GT = 1.000000; gamma distribution shape parameter α = 0.357175. In a BLASTn search of NCBI GenBank, the closest matches of the ITS sequence of *Pseudopalawania siamensis* (MFLUCC 17-1476, ex-holotype) is *Muyocopron geniculatum* with 81.40% (MK487737) similarity, respectively, was strain CBS. 721.95, the closest matches of the SSU sequence with 98.90% similarity, was *Neocochlearomyces chromolaenae* (strain BCC 68250, NG_065766), the closest matches of the TEF sequence with 95.17% similarity, was *Neomycoleptodiscus venezuelense* (strain CBS 100519, MK495978). The phylogram generated from maximum likelihood analysis ([Figure 2](#biomolecules-10-00569-f002){ref-type="fig"}) shows that our new strains clustered within Dothideomycetes and form a distinct lineage in the Muyocopronales, even though the clade is lacking bootstrap support.

3.2. Taxonomy {#sec3dot2-biomolecules-10-00569}
-------------

### 3.2.1. *Pseudopalawania* Mapook and K.D. Hyde, gen. nov. {#sec3dot2dot1-biomolecules-10-00569}

*Mycobank number*: MB834934.

*Etymology*: The generic epithet refers to the similarity to *Palawania*.

*Saprobic* on dead rachis of Arecaceae. **Sexual morph**: *Ascomata* superficial, solitary or scattered, sub-carbonaceous to carbonaceous, appearing as circular, flattened, dark brown to black spots, covering the host, without a subiculum, with a poorly developed basal layer and an irregular margin. *Ostioles* central. *Peridium* comprising dark brown or black to reddish-brown cells of *textura epidermoidea* to *textura angularis*. *Hamathecium* cylindrical to filiform, septate, hyaline, branching pseudoparaphyses. *Asci* eight-spored, bitunicate, fissitunicate, cylindric-clavate, straight or slightly curved, with an ocular chamber observed clearly when immature. *Ascospores* overlapping, 2--3-seriate, broadly fusiform to inequilateral, pointed ends, hyaline, 1-septate, constricted at the septum, guttulate when immature, surrounded by hyaline and thin layers of gelatinous sheath, observed clearly when mounted in Indian ink. **Asexual morph**: Undetermined.

*Type species: **Pseudopalawania siamensis*** Mapook and K.D. Hyde

### 3.2.2. ***Pseudopalawania siamensis*** Mapook and K.D. Hyde, sp. nov. {#sec3dot2dot2-biomolecules-10-00569}

*Mycobank number*: MB834935; [Figure 3](#biomolecules-10-00569-f003){ref-type="fig"}

*Etymology*: Named after the country from where the fungus was collected, using the former name of Siam.

*Saprobic* on dead rachis of *Caryota* sp. **Sexual morph**: *Ascomata* 29--40 µm high × 270--290(--315) µm diam. ($\overline{x}$ = 32.5 × 292 µm, n = 5), superficial, solitary or scattered, sub-carbonaceous to carbonaceous, appearing as circular, flattened, dark brown to black spots, covering the host, without a subiculum, with a poorly developed basal layer and an irregular margin. *Ostioles* central. *Peridium* 10--20 µm wide, comprising dark brown or black to reddish-brown cells of *textura epidermoidea* to *textura angularis*. *Hamathecium* comprising 1--2.5 µm wide, cylindrical to filiform, septate, hyaline, branching pseudoparaphyses. *Asci* 65--85 × 15--21 µm ($\overline{x}$ = 75 × 18 µm, n = 10), eight-spored, bitunicate, fissitunicate, cylindric-clavate, straight or slightly curved, with an ocular chamber observed clearly when immature. *Ascospores* 25--37 × 5--11 µm ($\overline{x}$ = 29 × 7 µm, n = 20), overlapping, 2--3-seriate, broadly fusiform to inequilateral, pointed ends, hyaline, 1-septate, constricted at the septum, guttulate when immature, surrounded by hyaline and thin layers of gelatinous sheath, observed clearly when mounted in Indian ink. **Asexual morph**: Undetermined.

**Culture characteristics**: Ascospores germinating on MEA within 24 hrs. at room temperature and germ tubes produced from the apex. Colonies on MEA circular, slightly raised, filamentous, mycelium white at the surface and initially creamy-white to pale brown in reverse, becoming dark brown from the centre of the colony with creamy-white at the margin.

**Pre-screening for antimicrobial activity**: *Pseudopalawania siamensis* (MFLUCC 17-1476) showed antimicrobial activity against *B. subtilis* with a 16 mm inhibition zone and against *M. plumbeus* with a 17 mm inhibition zone, observable as full inhibition, when compared to the positive control (26 mm and 17 mm, respectively), but no inhibition of *E. coli*.

**Material examined**: THAILAND, Nan Province, on dead rachis of *Caryota* sp. (Arecaceae), 23 September 2016, A. Mapook (MFLU 20-0353, **holotype**); ex-type culture MFLUCC 17-1476.

*Notes*: *Pseudopalawania* is similar to *Palawania* in its superficial and flattened ascomata, with hyaline, 1-septate ascospores, but differs in its peridium wall patterns, shape of asci (cylindric-clavate vs. inequilateral to ovoid) with an ocular chamber and shape of ascospores (broadly fusiform to inequilateral vs. oblong to broadly fusiform) with a thin layer of gelatinous sheath. The gelatinous sheath in *Palawania* is thicker \[[@B24-biomolecules-10-00569]\]. *Pseudopalawania* is also similar to *Muyocopron* in its superficial, flattened ascomata with similar peridium wall patterns, and asci with an ocular chamber; but differs in its sub-carbonaceous to carbonaceous ascomata, shape of asci and ascospores with surrounded by hyaline gelatinous sheath, 1-septate, while *Muyocopron* have coriaceous ascomata, aseptate ascospores with granular appearance and without gelatinous sheath \[[@B23-biomolecules-10-00569]\]. In addition, the genus was compared with genera in Microthyriaceae of which no DNA sequence data are available, but the holotype specimens were re-examined in previous studies with morphological descriptions and illustrations \[[@B94-biomolecules-10-00569],[@B95-biomolecules-10-00569],[@B96-biomolecules-10-00569],[@B97-biomolecules-10-00569],[@B98-biomolecules-10-00569],[@B99-biomolecules-10-00569]\], and neither of them matched our new fungus. Therefore, we introduce *Pseudopalawania* as a new genus with a new species *P. siamensis* from Thailand. The fungus is placed in Muyocopronaceae (Muyocopronales) with evidence from morphology and phylogeny.

3.3. Structure Elucidation of the New Compound {#sec3dot3-biomolecules-10-00569}
----------------------------------------------

HPLC chromatographic fractionation of the crude ethyl acetate extract from the yeast malt (YM 6.3) broth of *Pseudopalawania siamensis* resulted in the isolation of a new heterodimeric bistetrahydroxanthone, pseudopalawanone (**1**) together with three known tetrahydroxanthones, 4,4′-secalonic acid D (**2**) \[[@B100-biomolecules-10-00569]\], penicillixanthone A (**3**) \[[@B101-biomolecules-10-00569]\], paecilin B (**4**) \[[@B102-biomolecules-10-00569]\] and the benzophenone, cephalanone F (**5**) \[[@B103-biomolecules-10-00569]\] ([Figure 4](#biomolecules-10-00569-f004){ref-type="fig"}).

Pseudopalawanone (**1**) was obtained as optically active, pale yellow gum. The IR spectrum showed the presence of hydroxyl groups (3387 cm^−1^), carbonyl functionalities (1787, 1741 cm^−1^) and aromatic residues (1648, 1622 cm^−1^) while the UV spectrum was indicative of absorptions due to chromanone units \[[@B102-biomolecules-10-00569],[@B104-biomolecules-10-00569]\]. The molecular formula C~31~H~28~O~15~, indicating eighteen double bond equivalents, was established by HR-ESIMS based on its protonated pseudomolecular ion peak (\[M + H\]^+^) at *m/z* 641.1492. Observation of two sets of signals in the NMR spectra ([Figures S1 and S2](#app1-biomolecules-10-00569){ref-type="app"}) and careful comparison of the ^1^H and ^13^C NMR spectroscopic data of **1** ([Table 2](#biomolecules-10-00569-t002){ref-type="table"}) with those of **2**--**4** immediately revealed **1** to be an asymmetric dimer of an unfamiliar highly oxygenated tetrahydroxanthone subunit and 7-deoxyblennolide D \[[@B102-biomolecules-10-00569]\]. Thus, the gross structure of the latter fragment along with its connection to 7-deoxyblennolide D was established through analysis of 1D and 2D NMR spectroscopic data and will be the subject of the following discussions. The ^13^C and HSQC-DEPT edited spectra ([Figure S3](#app1-biomolecules-10-00569){ref-type="app"}) showed the presence of fifteen resonances comprised of a ketone (δ*~C~* 194.9), a carboxyl group of an ester functionality (δ*~C~* 176.6), a hemiacetal carbon (δ*~C~* 108.9), four quaternary aromatic carbons (δ*~C~* 106.8, 117.6, 158.3, 160.1), two aromatic methine carbons (δ*~C~* 108.3, 143.8), two aliphatic quaternary carbons (δ*~C~* 73.6, 84.7), two methine carbons (δ*~C~* 30.4, 74.1), a methylene carbon (δ*~C~* 33.8) and a methyl group (δ*~C~* 14.9). The ^1^H and COSY NMR spectrum ([Figure S4](#app1-biomolecules-10-00569){ref-type="app"}) revealed two ortho-coupled aromatic protons (^3^*J* = 8.6 Hz) for H--3 (δ*~H~* 7.82) and H--4 (δ*~H~* 6.77), and a seven-proton spin system comprised of H--5 (δ*~H~* 4.44) -- H--6 (δ*~H~* 2.23) (H~3~--11) (δ*~H~* 1.20) -- H~2~--7 (δ*~H~* 2.12, 2.36). A C--2 substituted 1-hydroxychromanone unit was elucidated on the basis of HMBC correlations of chelated 1-OH (δ*~H~* 11.35) with C--1 (δ*~C~* 160.1), C--2 (δ*~C~* 117.6) and C--9a (δ*~C~* 106.8) and of H--4 (δ*~H~* 6.77) with C--2 and C--4a (δ*~C~* 158.3). The remaining portion of the molecule was constructed through HMBC correlations of H--6 (δ*~H~* 2.13) and H--11 (δ*~H~* 1.20) with C--8 (δ*~C~* 108.9), of H--5 (δ*~H~* 4.44) with C--8a (δ*~C~* 73.6), C--10a (δ*~C~* 84.7) and C--12 (δ*~C~* 176.6), and of H~2~--7 (δ*~H~* 2.12, 2.36) with C--8 and C--8a. The chemical shifts assigned for C--8 and C--12 were ascribed to hemiacetal and *γ*-lactone moieties, respectively, by using a combination of 2D NMR experiments ([Figure 5](#biomolecules-10-00569-f005){ref-type="fig"}). The lactone ester was plausibly attached to C--8 forming a *γ*-hydroxylactone subunit of a \[3.2.1\] bicyclic structure. The remaining 17 mass units was attributed to a hydroxyl group attached to the *〈*−carbon (C--8a) of the chromanone substructure. This unusual tetrahydroxanthone motif could putatively originate presumably from *α* hydroxylation of the keto form of blennolide A, followed by nucleophilic attack of the hydrolyzed C--12 methyl ester ([Figure 6](#biomolecules-10-00569-f006){ref-type="fig"}). The relative configurations of C--5 and C--6 were readily established to be similar with blennolide A by the coupling constant (^3^*J*~5,6~ = 4.0 Hz) and the chemical shifts as 5*S\**, 6*S\** while that of C--10a was assigned *R\** based on the observed positive n-π\* CD transition at around 331 nm \[[@B104-biomolecules-10-00569]\]. The chirality of C--8a cannot be established using available methods due to its remoteness to most protons in the molecule.

The linkage between the chromanone subunit and the *©*−lactone in the 7-deoxyblennolide D monomer was indicated by the HMBC correlation of H--5′ (δ*~H~* 4.38) with C--10a′ (δ*~C~* 84.8) and C--12′ (δ*~C~* 168.5). The C--5′*S\** and C--6′*S\** relative configurations in the lactone moiety were established by coupling constant analysis (^3^*J*~5,6~ = 2.5 Hz) depicting a pseudodiaxial orientation for H--5′/H--6′ and the NOE ([Figures S6 and S7](#app1-biomolecules-10-00569){ref-type="app"}) noted between H--5′ and H--8a'*a* (δ*~H~* 3.14), H--8a′*b* (δ*~H~* 2.98) and H--6′ (δ*~H~* 2.65), and that of H--6′ and H~3~--13 (δ*~H~* 3.80) \[[@B102-biomolecules-10-00569]\]. The spatial arrangements in ring C were similar to 7-deoxyblennolide D corroborated by NOE correlations between H--5′, H~3~--11′ (δ*~H~* 1.16) and H--7′b (δ*~H~* 1.99). Finally, the relative configuration of C-10a′ may be tentatively assigned as *S\** on the basis of negative π\*-π\* transitions below 330 nm and positive n-π\* transitions at 346 nm in the ECD spectrum ([Figure S9](#app1-biomolecules-10-00569){ref-type="app"}) of **1** \[[@B104-biomolecules-10-00569]\]. The overall relative configuration of the blennolide-type tetrahydroxanthone substructure is 5*S\**, 6*S\**, and 10a*S\** thus, structurally similar to 7-deoxyblennolide D.

The planar structure of **1** was established by connecting the two monomers through the linkage of C--2 (δ*~C~* = 117.6) of the oxidized secalonic acid subunit and C--4′ (δ*~C~* 114.0) of 7-deoxyblennolide D evidenced by the diagnostic HMBC correlations of H--3 (δ*~H~* 7.82) to C--4′ and H--3′ (δ*~H~* 7.54) to C--2. The axial configuration of C-2/C-4′ was assigned as *P* based on the CD spectrum of **1** which showed a positive first Cotton effect (225 nm, De = −6.41) and a negative second cotton effect (250 nm, De = +3.15). Thus, compound **1** was given the trivial name pseudopalawanone. To establish unambiguously its relative and absolute configurations especially C--8a in the blennolide A substructure and C--10a' in the 7-deoxyblennolide D substructure, we suggest additional experiments such as asymmetric total synthesis, derivatization with heavy atom/s followed by single crystal x-ray diffraction and/or further ECD-TDDFT measurements and calculations.

3.4. Biological Activity of Compounds ***1***--***5*** {#sec3dot4-biomolecules-10-00569}
------------------------------------------------------

The polyketides **1**--**5** were evaluated for their antimicrobial activity against selected microorganisms ([Table 3](#biomolecules-10-00569-t003){ref-type="table"}) and cytotoxicity against two mammalian cell lines, HeLa cells KB3.1 and mouse fibroblast cell line L929 ([Table 4](#biomolecules-10-00569-t004){ref-type="table"}). The starting concentration for antimicrobial assay and cytotoxicity assay were 66.7 and 300 µg/mL, respectively and the substances were dissolved in MeOH (1 mg/mL). MeOH was used as the negative control and showed no activity against the tested organisms and mammalian cell lines. Results were expressed as MIC or minimum inhibitory concentration (μg/mL) and IC~50~ or half maximal inhibitory concentration (μM) ([Table 3](#biomolecules-10-00569-t003){ref-type="table"} and [Table 4](#biomolecules-10-00569-t004){ref-type="table"}). The known compounds **4** and **5** showed neither antimicrobial nor cytotoxic activities. The dimeric tetrahydroxanthone 4,4′-secalonic acid D (**2**) showed inhibition against the pathogenic fungus *Candida albicans* while penicillixanthone A (**3**) inhibited *Mucor hiemalis* with activities comparable to the positive drug control nystatin. Prominent activities were observed for compounds **2** and **3** against *Bacillus subtilis* with MIC values of 1.0 and 4.2 μg/mL, respectively. Compound **2** also showed inhibitory activity against all Gram-positive bacteria (*Bacillus subtilis*, *Micrococcus luteus*, *Mycobacterium smegmatis*, and *Staphylococcus aureus*), while compounds **1** and **3** also showed inhibitory activity against the Gram-positive bacterium, *Mycobacterium smegmatis*. In general, only the dimeric tetrahydroxanthones **1**--**3** exhibited activity against fungi and bacteria with the secalonic acid-bearing derivatives **2** and **3** exhibiting better antimicrobial profile. However, the dimeric compounds **1**--**3** also showed moderate cytotoxic activities against two mammalian cell lines ([Table 4](#biomolecules-10-00569-t004){ref-type="table"}). These inhibitory concentrations for cytotoxic activities are given traditionally in molar concentrations, but if they are calculated in µg/mL, the IC~50~ values would be equivalent to a range of 2--25 µg/mL (i.e., the same or only slightly higher activity range as compared to the MIC). This observation precludes the potential use of these metabolites as candidates for the development of antibiotics, because their selectivity indices are far too low. In addition, the fact that they are broadly active against both, prokaryotic and eukaryotic test organisms suggests that they may address multiple targets and are therefore less suitable for development of any drug.

Some information on these and chemically related compounds is even available from the literature. Compound **2** (4,4′-secalonic acid D; 4,4′-SAD) is a regioisomeric structure to SAD with 2,2′-biarylic connectivity, belonging to the secalonic acid family. This compound class has long been known to have non-selective antimicrobial and other biological activities \[[@B100-biomolecules-10-00569],[@B101-biomolecules-10-00569],[@B102-biomolecules-10-00569],[@B103-biomolecules-10-00569],[@B104-biomolecules-10-00569],[@B105-biomolecules-10-00569],[@B106-biomolecules-10-00569]\]. The compound 4,4′-SAD (2) itself was recently reported to have low toxicity with "potent" antitumor activity against several cancer cell lines through cell proliferation inhibition and apoptosis induction \[[@B100-biomolecules-10-00569]\]. However, when compared to the precursor for a marketed drug, epothilone, which we used as a positive control in our standard cytotoxicity assays ([Table 4](#biomolecules-10-00569-t004){ref-type="table"}), the activities of all the metabolites from *Pseudopalawania siamensis* are much weaker. Promising candidate compounds for anticancer therapy should have at least activities in the 100 nM range such assays. Penicillixanthone A (**3**) was also already shown to possess moderate antibacterial activity against four tested bacterial strains (*M. luteus*, *Pseudoalteromonas nigrifaciens*, *E. coli* and *B. subtilis* \[[@B100-biomolecules-10-00569]\], and its moderate cytotoxic effects on MDA-MB-435 human melanoma cells and SW620 human colorectal adenocarcinoma cell lines had been previously reported \[[@B101-biomolecules-10-00569]\]. Furthermore, compound **3** was previously isolated from the marine-derived fungus *Aspergillus fumigatus*, and was reported to exhibit anti-HIV-1 activities by inhibiting CCR5-tropic HIV-1 and CXCR4-tropic HIV-1 infection \[[@B103-biomolecules-10-00569]\]. These data also point toward non-selective effects of this metabolite in biological systems.

4. Conclusions {#sec4-biomolecules-10-00569}
==============

The current study showed that new genera and species of tropical fungi can still yield numerous new and interesting secondary metabolites. Even though the preliminary characterization of the metabolites **1**--**5** indicates that they act non-selectively in biological systems, their further evaluation could result in the discovery of additional, more specific biological effects. In any case, it is worthwhile to further explore tropical fungi whose cultures result from taxonomic and biodiversity studies for the production of secondary metabolites and other potentially beneficial properties \[[@B107-biomolecules-10-00569]\].
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![HPLC-(DAD)-UV chromatogram of the crude ethyl acetate extract of the culture filtrate of *Pseudopalawania siamensis* (MFLUCC 17-1476).](biomolecules-10-00569-g001){#biomolecules-10-00569-f001}

![Phylogram generated from maximum likelihood analysis based on combined dataset of LSU, SSU, RPB2, ITS and TEF sequence data. Bootstrap support values for maximum likelihood (ML) equal to or greater than 60% and Bayesian posterior probabilities (PP) equal to or greater than 0.90 are given above the nodes. Newly generated sequences are in dark red bold. The tree is rooted with Lecanoromycetes. Small red arrows point towards the bootstrap values of the clades representing genera of the order Muyocopronales, while some other monophyletic clades that represent monophyletic clades have been collapses (indicated by red triangles).](biomolecules-10-00569-g002){#biomolecules-10-00569-f002}

![***Pseudopalawania siamensis*** (**holotype**) (**a**,**b**) Appearance of ascomata on substrate. (**c**) Squash mounts showing ascomata. (**d**) Section of ascoma. (**e**) Peridium. (**f**) Pseudoparaphyses. (**g**--**j**) asci. (**k**--**p**) Ascospores. (**q**) Ascospores in Indian ink. **Scale bars**: a, b = 500 µm, c, d = 100 µm, g--j = 50 µm, e, k--q = 10 µm, f = 5 µm.](biomolecules-10-00569-g003){#biomolecules-10-00569-f003}

![Secondary metabolites from *Pseudopalawania siamensis*.](biomolecules-10-00569-g004){#biomolecules-10-00569-f004}

![COSY (bold bonds), HMBC (red arrows) (**a**), and ROESY (blue arrows) (**b**) correlations in pseudopalawanone (**1**).](biomolecules-10-00569-g005){#biomolecules-10-00569-f005}

![Plausible biogenetic pathway towards pseudopalawanone (**1**).](biomolecules-10-00569-g006){#biomolecules-10-00569-f006}

biomolecules-10-00569-t001_Table 1

###### 

Taxa used in this study and their GenBank accession numbers. New sequences generated in the present study are in bold.

  Taxa                                           Strain No. ^1^        GenBank Accession Numbers ^2^   References                                              
  ---------------------------------------------- --------------------- ------------------------------- -------------- ---------- -------------- -------------- ------------------------------------------------------------
  ***Acrospermum adeanum***                      M133                  EU940104                        EU940031       EU940320   EU940180       \-             Stenroos et al. \[[@B26-biomolecules-10-00569]\]
  ***Acrospermum compressum***                   M151                  EU940084                        EU940012       EU940301   EU940161       \-             Stenroos et al. \[[@B26-biomolecules-10-00569]\]
  ***Acrospermum gramineum***                    M152                  EU940085                        EU940013       EU940302   EU940162       \-             Stenroos et al. \[[@B26-biomolecules-10-00569]\]
  ***Alternaria alternata***                     KFRD-18               KX609781                        KX609769       \-         KX346897       KY094931       Li et al. \[[@B27-biomolecules-10-00569]\]
  ***Alternariaster bidentis***                  CBS 134021            KC609341                        \-             KC609347   KC609333       \-             Alves et al. \[[@B28-biomolecules-10-00569]\]
  ***Antennariella placitae***                   CBS:124785            GQ303299                        \-             \-         MH863403       \-             Cheewangkoon et al. \[[@B29-biomolecules-10-00569]\]
  ***Arxiella dolichandrae***                    CBS 138853            KP004477                        \-             \-         KP004449       \-             Crous et al. \[[@B30-biomolecules-10-00569]\]
  ***Arxiella terrestris***                      CBS 268.65            MH870201                        \-             \-         MH858565       \-             Vu et al. \[[@B31-biomolecules-10-00569]\]
  ***Asterina fuchsiae***                        TH590                 GU586216                        GU586210       \-         \-             \-             Hofmann et al. \[[@B32-biomolecules-10-00569]\]
  ***Asterina phenacis***                        TH589                 GU586217                        GU586211       \-         \-             \-             Hofmann et al. \[[@B32-biomolecules-10-00569]\]
  ***Bambusicola massarinia***                   MFLUCC 11-0389        JX442037                        JX442041       KU940169   JX442033       \-             Dai et al. \[[@B33-biomolecules-10-00569]\]
  ***Bambusicola splendida***                    MFLUCC 11-0439        JX442038                        JX442042       \-         JX442034       \-             Dai et al. \[[@B33-biomolecules-10-00569]\]
  ***Botryosphaeria agaves***                    MFLUCC 11-0125        JX646808                        JX646825       \-         JX646791       JX646856       Liu et al. \[[@B34-biomolecules-10-00569]\]
  ***Botryosphaeria tsugae***                    AFTOL-ID 1586         DQ767655                        \-             DQ767644   \-             DQ677914       Schoch et al. \[[@B35-biomolecules-10-00569]\]
  ***Calicium salicinum***                       CBS 100898            KF157982                        KF157970       KF157998   \-             \-             Beimforde et al. \[[@B36-biomolecules-10-00569]\]
  ***Calicium viride***                          10-VII-1997 (DUKE)    AF356670                        AF356669       AY641031   \-             \-             Lutzoni et al. \[[@B37-biomolecules-10-00569]\]
  ***Camarosporium quaternatum***                CBS 483.95            GU301806                        GU296141       GU357761   KY929149       GU349044       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Capnodium salicinum***                      AFTOL-ID 937          DQ678050                        DQ677997       \-         \-             DQ677889       Schoch et al. \[[@B37-biomolecules-10-00569]\]
  ***Caryospora minima***                        \-                    EU196550                        EU196551       \-         \-             \-             Cai and Hyde \[[@B39-biomolecules-10-00569]\]
  ***Chaetothyriothecium elegans***              CPC 21375             KF268420                        \-             \-         \-             \-             Hongsanan et al. \[[@B40-biomolecules-10-00569]\]
  ***Corynespora cassiicola***                   CBS 100822            GU301808                        GU296144       GU371742   \-             GU349052       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Corynespora smithii***                      CABI 5649b            GU323201                        \-             GU371783   \-             GU349018       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Cucurbitaria berberidis***                  MFLUCC 11-0387        KC506796                        KC506800       \-         \-             \-             Hyde et al. \[[@B41-biomolecules-10-00569]\]
  ***Cyphelium inquinans***                      Tibell 22283 (UPS)    AY453639                        U86695         \-         AY450584       \-             Tibell \[[@B42-biomolecules-10-00569]\]
  ***Cyphelium tigillare***                      Tibell 22343 (UPS)    AY453641                        AF241545       \-         AY452497       \-             Tibell \[[@B42-biomolecules-10-00569]\]
  ***Cystocoleus ebeneus***                      L161                  EU048578                        EU048571       \-         \-             \-             Muggia et al. \[[@B43-biomolecules-10-00569]\]
  ***Didymella exigua***                         CBS 183.55            JX681089                        EU754056       GU371764   MH857436       KR184187       Verkley et al. \[[@B44-biomolecules-10-00569]\]
  ***Didymosphaeria rubi-ulmifolii***            MFLUCC 14-0023        KJ436586                        KJ436588       \-         \-             \-             Ariyawansa et al. \[[@B45-biomolecules-10-00569]\]
  ***Dothiora cannabinae***                      AFTOL ID 1359         DQ470984                        DQ479933       DQ470936   \-             DQ471107       Spatafora et al. \[[@B46-biomolecules-10-00569]\]
  ***Dyfrolomyces phetchaburiensis***            MFLUCC 15-0951        MF615402                        MF615403       \-         \-             \-             Hyde et al. \[[@B47-biomolecules-10-00569]\]
  ***Dyfrolomyces rhizophorae***                 BCC15481              \-                              KF160009       \-         \-             \-             Pang et al. \[[@B48-biomolecules-10-00569]\]
  ***Dyfrolomyces rhizophorae***                 JK 5456A              GU479799                        \-             \-         \-             GU479860       Suetrong et al. \[[@B49-biomolecules-10-00569]\]
  ***Dyfrolomyces thailandica***                 MFLU 16-1173          KX611366                        KX611367       \-         \-             \-             Hyde et al. \[[@B50-biomolecules-10-00569]\]
  ***Dyfrolomyces thamplaensis***                MFLUCC 15-0635        KX925435                        KX925436       \-         \-             KY814763       Zhang et al. \[[@B51-biomolecules-10-00569]\]
  ***Dyfrolomyces tiomanensis***                 NTOU3636              KC692156                        KC692155       \-         \-             KC692157       Pang et al. \[[@B48-biomolecules-10-00569]\]
  ***Elsinoe fawcettii***                        CPC 18535             JN940382                        JN940559       \-         KX887207       KX886853       Schoch et al. \[[@B52-biomolecules-10-00569]\]
  ***Elsinoe verbenae***                         CPC 18561             JN940391                        JN940562       \-         KX887298       KX886942       Schoch et al. \[[@B53-biomolecules-10-00569]\]
  ***Extremus antarcticus***                     CCFEE 5312            KF310020                        \-             KF310086   KF309979       \-             Egidi et al. \[[@B54-biomolecules-10-00569]\]
  ***Gonatophragmium triuniae***                 CBS 138901            KP004479                        \-             \-         KP004451       \-             Crous et al. \[[@B30-biomolecules-10-00569]\]
  ***Helicascus nypae***                         BCC 36751             GU479788                        GU479754       GU479826   \-             GU479854       Suetrong et al. \[[@B49-biomolecules-10-00569]\]
  ***Julella avicenniae***                       BCC 20173             GU371822                        GU371830       GU371786   \-             GU371815       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Karschia cezannei***                        Cezanne-Eichler B26   KP456152                        \-             \-         \-             \-             Ertz and Diederich \[[@B55-biomolecules-10-00569]\]
  ***Katumotoa bambusicola***                    KT 1517a              AB524595                        AB524454       AB539095   NR_154103      AB539108       Tanaka et al. \[[@B56-biomolecules-10-00569]\]
  ***Labrocarpon canariense***                   Ertz 16907 (BR)       KP456157                        \-             \-         \-             \-             Ertz and Diederich \[[@B55-biomolecules-10-00569]\]
  ***Lentithecium fluviatile***                  CBS 123090            FJ795450                        FJ795492       FJ795467   \-             \-             Zhang et al. \[[@B57-biomolecules-10-00569]\]
  ***Leptodiscella africana***                   CBS 400.65            MH870275                        \-             \-         MH858635       \-             Vu et al. \[[@B31-biomolecules-10-00569]\]
  ***Leptodiscella brevicatenata***              FMR 10885             FR821311                        \-             \-         FR821312       \-             Madrid et al. \[[@B58-biomolecules-10-00569]\]
  ***Leptodiscella chlamydospora***              MUCL 28859            FN869567                        \-             \-         FR745398       \-             Madrid et al. \[[@B58-biomolecules-10-00569]\]
  ***Leptodiscella rintelii***                   CBS 144927            LR025181                        \-             \-         LR025180       \-             Papendorf \[[@B52-biomolecules-10-00569]\]
  ***Leptosphaeria doliolum***                   MFLUCC 15-1875        KT454719                        KT454734       \-         KT454727       \-             Ariyawansa et al. \[[@B59-biomolecules-10-00569]\]
  ***Leptosphaerulina australis***               CBS 317.83            EU754166                        GU296160       GU371790   MH861604       GU349070       de Gruyter et al. \[[@B60-biomolecules-10-00569]\]
  ***Leptoxyphium cacuminum***                   MFLUCC10-0049         JN832602                        JN832587       \-         \-             \-             Chomnunti et al. \[[@B61-biomolecules-10-00569]\]
  ***Lophiotrema nucula***                       CBS 627 86            GU301837                        GU296167       GU371792   LC194497       GU349073       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Lophium mytilinum***                        AFTOL-ID 1609         DQ678081                        DQ678030       DQ677979   \-             DQ677926       Schoch et al. \[[@B35-biomolecules-10-00569]\]
  ***Massarina bambusina***                      H 4321                AB807536                        AB797246       \-         LC014578       AB808511       Tanaka et al. \[[@B56-biomolecules-10-00569]\]
  ***Massarina eburnea***                        CBS 473.64            GU301840                        GU296170       GU371732   \-             GU349040       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Melanomma pulvis-pyrius***                  CBS 371 75            GU301845                        FJ201989       GU371798   \-             GU349019       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Melaspileopsis*** **cf. *diplasiospora***   Ertz 16247 (BR)       KP456164                        \-             \-         \-             \-             Ertz and Diederich \[[@B55-biomolecules-10-00569]\]
  ***Melomastia maolanensis***                   GZCC 16-0102          KY111905                        KY111906       \-         \-             KY814762       Zhang et al. \[[@B51-biomolecules-10-00569]\]
  ***Microsphaeropsis olivacea***                CBS 233 77            GU237988                        \-             KT389643   MH861055       \-             Aveskamp et al. \[[@B62-biomolecules-10-00569]\]
  ***Microthyrium buxicola***                    MFLUCC 15-0213        KT306552                        KT306550       \-         \-             \-             Ariyawansa et al. \[[@B63-biomolecules-10-00569]\]
  ***Microthyrium microscopicum***               CBS 115976            GU301846                        GU296175       GU371734   \-             GU349042       Schoch et al. \[[@B44-biomolecules-10-00569]\]
  ***Multiseptospora thailandica***              MFLUCC 11-0183        KP744490                        KP753955       \-         KP744447       KU705657       Liu et al. \[[@B64-biomolecules-10-00569]\]
  ***Murispora rubicunda***                      IFRD 2017             FJ795507                        GU456308       \-         \-             GU456289       Zhang et al. \[[@B57-biomolecules-10-00569]\]
  ***Muyocopron alcornii***                      BRIP 43897            MK487708                        \-             MK492712   MK487735       MK495956       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron atromaculans***                  MUCL 34983            MK487709                        \-             MK492713   MK487736       MK495957       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron castanopsis***                   MFLUCC 10-0042        \-                              JQ036225       \-         \-             \-             Mapook et al. \[[@B23-biomolecules-10-00569]\]
  ***Muyocopron castanopsis***                   MFLUCC 14-1108        KU726965                        KU726968       KY225778   **MT137784**   **MT136753**   Mapook et al. \[[@B23-biomolecules-10-00569]\]
  ***Muyocopron chromolaenae***                  MFLUCC 17-1513        MT137876                        MT137881       MT136761   MT137777       MT136756       Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Muyocopron chromolaenicola***               MFLUCC 17-1470        MT137877                        MT137882       \-         MT137778       MT136757       Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Muyocopron coloratum***                     CBS 720.95            MK487710                        \-             MK492714   NR_160197      MK495958       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron dipterocarpi***                  MFLUCC 14-1103        KU726966                        KU726969       KY225779   **MT137785**   **MT136754**   Mapook et al. \[[@B23-biomolecules-10-00569]\]
  ***Muyocopron dipterocarpi***                  MFLUCC 17-0075        MH986833                        MH986829       \-         MH986837       \-             Senwanna et al. \[[@B65-biomolecules-10-00569]\]
  ***Muyocopron dipterocarpi***                  MFLUCC 17-0354        MH986834                        MH986830       \-         MH986838       \-             Senwanna et al. \[[@B65-biomolecules-10-00569]\]
  ***Muyocopron dipterocarpi***                  MFLUCC 17-0356        MH986835                        MH986831       \-         MH986839       \-             Senwanna et al. \[[@B66-biomolecules-10-00569]\]
  ***Muyocopron dipterocarpi***                  MFLUCC 18-0470        MK348001                        MK347890       \-         MK347783       \-             Jayasiri et al. \[[@B67-biomolecules-10-00569]\]
  ***Muyocopron garethjonesii***                 MFLU 16-2664          KY070274                        KY070275       \-         \-             \-             Tibpromma et al. \[[@B68-biomolecules-10-00569]\]
  ***Muyocopron geniculatum***                   CBS 721.95            MK487711                        \-             MK492715   MK487737       MK495959       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron heveae***                        MFLUCC 17-0066        MH986832                        MH986828       \-         MH986836       \-             Senwanna et al. \[[@B66-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 141029            MK487712                        \-             MK492716   MK487738       MK495960       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      IMI 324533            MK487713                        \-             MK492717   MK487739       MK495961       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 719.95            MK487714                        \-             MK492718   MK487740       MK495962       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 141033            MK487715                        \-             MK492719   MK487741       MK495963       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      URM 7802              MK487716                        \-             MK492720   MK487742       MK495964       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      URM 7801              MK487717                        \-             MK492721   MK487743       \-             Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 127677            MK487718                        \-             MK492722   MK487744       MK495965       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145310            MK487719                        \-             MK492723   MK487745       MK495966       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145315            MK487720                        \-             MK492724   MK487746       MK495967       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145313            MK487721                        \-             MK492725   MK487747       MK495968       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145309            MK487722                        \-             MK492726   MK487748       MK495969       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145314            MK487723                        \-             MK492727   MK487749       MK495970       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145311            MK487724                        \-             MK492728   MK487750       \-             Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145312            MK487725                        \-             MK492729   MK487751       MK495971       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      CBS 145316            MK487726                        \-             MK492730   MK487752       MK495972       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron laterale***                      FMR13797              MK874616                        \-             MK875802   MK874615       MK875803       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLUCC 10-0041        JQ036230                        JQ036226       \-         \-             \-             Mapook et al. \[[@B23-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLUCC 14-1106        KU726967                        KU726970       KY225780   **MT137786**   **MT136755**   Mapook et al. \[[@B23-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLU 18-2087          MK347930                        MK347821       \-         MK347716       \-             Jayasiri et al. \[[@B66-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLU 18-2088          MK347931                        MK347822       \-         MK347717       \-             Jayasiri et al. \[[@B66-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLUCC 16-0962        MK348034                        MK347923       \-         \-             \-             Jayasiri et al. \[[@B66-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLUCC 17-1465        MT137878                        MT137883       \-         MT137779       MT136758       Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLUCC 17-1466        MT137879                        MT137884       \-         MT137780       MT136759       Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Muyocopron lithocarpi***                    MFLUCC 17-1500        MT137880                        MT137885       MT136762   MT137781       MT136760       Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Muyocopron zamiae***                        CBS 203.71            MK487727                        \-             MK492731   \-             MK495973       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Mycoleptodiscus endophytica***              MFLUCC 17-0545        MG646946                        MG646978       \-         MG646961       MG646985       Tibpromma et al. \[[@B69-biomolecules-10-00569]\]
  ***Mycoleptodiscus suttonii***                 CBS 276.72            MK487728                        \-             MK492732   MK487753       MK495974       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Mycoleptodiscus suttonii***                 CBS 141030            MK487729                        \-             MK492733   \-             MK495975       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Mycoleptodiscus terrestris***               CBS 231.53            MK487730                        \-             MK492734   MK487754       MK495976       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Mycoleptodiscus terrestris***               IMI 159038            MK487731                        \-             MK492735   MK487755       MK495977       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Myriangium duriaei***                       CBS 260.36            NG_027579                       AF242266       KT216528   MH855793       \-             Schoch et al. \[[@B35-biomolecules-10-00569]\]
  ***Myriangium hispanicum***                    CBS 247.33            GU301854                        GU296180       GU371744   MH855426       GU349055       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Mytilinidion rhenanum***                    CBS 135.34            FJ161175                        FJ161136       FJ161115   \-             FJ161092       Boehm et al. \[[@B70-biomolecules-10-00569]\]
  ***Natipusilla decorospora***                  AF236 1a              HM196369                        HM196376       \-         \-             \-             Ferrer et al. \[[@B71-biomolecules-10-00569]\]
  ***Natipusilla naponensis***                   AF217 1a              HM196371                        HM196378       \-         \-             \-             Ferrer et al. \[[@B71-biomolecules-10-00569]\]
  ***Neocochlearomyces chromolaenae***           BCC 68250             MK047514                        MK047552       \-         MK047464       MK047573       Crous et al. \[[@B21-biomolecules-10-00569]\]
  ***Neocochlearomyces chromolaenae***           BCC 68251             MK047515                        MK047553       \-         MK047465       MK047574       Crous et al. \[[@B21-biomolecules-10-00569]\]
  ***Neocochlearomyces chromolaenae***           BCC 68252             MK047516                        MK047554       \-         MK047466       MK047575       Crous et al. \[[@B21-biomolecules-10-00569]\]
  ***Neocylindroseptoria pistaciae***            CBS 471.69            KF251656                        \-             KF252161   KF251152       KF253112       Quaedvlieg et al. \[[@B65-biomolecules-10-00569]\]
  ***Neomycoleptodiscus venezuelense***          CBS 100519            MK487732                        \-             MK492736   MK487756       MK495978       Hernández-Restrepo et al. \[[@B22-biomolecules-10-00569]\]
  ***Palawania thailandensis***                  MFLUCC 14-1121        KY086493                        KY086495       KY086496   **MT137787**   \-             Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Palawania thailandensis***                  MFLU 16-1871          KY086494                        \-             \-         **MT137788**   \-             Mapook et al. \[[@B24-biomolecules-10-00569]\]
  ***Paramycoleptodiscus albizziae***            CPC 27552             MH878220                        \-             \-         \-             \-             Vu et. al. \[[@B31-biomolecules-10-00569]\]
  ***Paramycoleptodiscus albizziae***            CBS 141320            KX228330                        \-             MK492737   KX228279       MK495979       Crous et. al. \[[@B72-biomolecules-10-00569]\]
  ***Phaeodimeriella cissampeli***               MFLU 16-0558          KU746806                        KU746808       KU746810   \-             KU746812       Mapook et. al. \[[@B73-biomolecules-10-00569]\]
  ***Phaeodimeriella dilleniae***                MFLU 14-0013          KU746805                        KU746807       KU746809   \-             KU746811       Mapook et. al. \[[@B73-biomolecules-10-00569]\]
  ***Phaeotrichum benjaminii***                  CBS 541.72            AY004340                        AY016348       GU357788   MH860561       DQ677892       Lumbsch et. al. \[[@B74-biomolecules-10-00569]\]
  ***Physcia aipolia***                          AFTOL-ID 84           DQ782904.1                      DQ782876       DQ782862   DQ782836       DQ782892       James et. al. \[[@B75-biomolecules-10-00569]\]
  ***Piedraia hortae***                          CBS 480.64            GU214466                        \-             KF902289   GU214647       \-             Crous et. al. \[[@B76-biomolecules-10-00569]\]
  ***Platystomum crataegi***                     MFLUCC 14-0925        KT026109                        KT026113       \-         NG_063580      KT026121       Thambugala et. al. \[[@B77-biomolecules-10-00569]\]
  ***Pleomassaria siparia***                     AFTOL-ID 1600         DQ678078                        DQ678027       DQ677976   \-             DQ677923       Schoch et. al. \[[@B35-biomolecules-10-00569]\]
  ***Pleospora herbarum***                       IT 956                KP334709                        KP334729       KP334733   KP334719       KP334731       Ariyawansa et. al. \[[@B78-biomolecules-10-00569]\]
  ***Preussia funiculata***                      CBS 659.74            GU301864                        GU296187       GU371799   \-             GU349032       Schoch et. al. \[[@B38-biomolecules-10-00569]\]
  ***Pseudomassariosphaeria bromicola***         IT-1333               KT305994                        KT305996       \-         KT305998       KT305999       Ariyawansa et. al. \[[@B63-biomolecules-10-00569]\]
  ***Pseudopalawania siamensis***                **MFLUCC 17-1476a**   \-                              **MT137789**   \-         **MT137782**   **MT136752**   **This study**
  ***Pseudopalawania siamensis***                **MFLUCC 17-1476b**   \-                              **MT137790**   \-         **MT137783**   \-             **This study**
  ***Pseudostrickeria muriformis***              MFLUCC 13-0764        KT934254                        KT934258       \-         \-             KT934262       Tian et. al. \[[@B79-biomolecules-10-00569]\]
  ***Pseudovirgaria grisea***                    CPC 19134             JF957614                        \-             \-         JF957609       \-             Braun et. al. \[[@B80-biomolecules-10-00569]\]
  ***Pseudovirgaria hyperparasitica***           CPC 10753             EU041824                        \-             \-         EU041767       \-             Arzanlou et. al. \[[@B81-biomolecules-10-00569]\]
  ***Ramularia endophylla***                     CBS 113265            KF251833                        \-             KP894673   KF251220       \-             Verkley et. al. \[[@B82-biomolecules-10-00569]\]
  ***Rasutoria pseudotsugae***                   rapssd                EF114704                        EF114729       \-         EF114687       \-             Winton et al. \[[@B83-biomolecules-10-00569]\]
  ***Rasutoria tsugae***                         ratstk                EF114705                        EF114730       GU371809   EF114688       \-             Winton et al. \[[@B83-biomolecules-10-00569]\]
  ***Salsuginea ramicola***                      KT 2597.1             GU479800                        GU479768       GU479833   \-             GU479861       Suetrong et al. \[[@B49-biomolecules-10-00569]\]
  ***Schizothyrium pomi***                       CBS 406.61            EF134949                        \-             KF902384   \-             \-             Batzer et al. \[[@B84-biomolecules-10-00569]\]
  ***Setoapiospora thailandica***                MFLUCC 17-1426        MN638847                        MN638851       \-         MN638862       MN648731       Hyde et al. \[[@B85-biomolecules-10-00569]\]
  ***Stictographa lentiginosa***                 Ertz 17570 (BR)       KP456170                        \-             \-         \-             \-             Ertz and Diederich \[[@B55-biomolecules-10-00569]\]
  ***Sympoventuria capensis***                   CBS 120136            KF156104                        KF156094       \-         KF156039       \-             Samerpitak et al. \[[@B86-biomolecules-10-00569]\]
  ***Teratosphaeria fibrillosa***                CBS 121707            GU323213                        GU296199       GU357767   MH863138       KF903305       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Trichodelitschia munkii***                  Kruys 201 (UPS)       DQ384096                        DQ384070       \-         \-             \-             Kruys et al. \[[@B87-biomolecules-10-00569]\]
  ***Tumidispora*** ***shoreae***                MFLUCC 14-0574        KT314074                        KT314076       \-         \-             \-             Ariyawansa et al. \[[@B63-biomolecules-10-00569]\]
  ***Uwebraunia commune***                       NC132C1d              \-                              \-             KT216546   \-             \-             Ismail et al. \[[@B88-biomolecules-10-00569]\]
  ***Venturia inaequalis***                      CBS 594.70            GU301879                        GU296205       GU357757   KF156040       GU349022       Schoch et al. \[[@B38-biomolecules-10-00569]\]
  ***Xenolophium applanatum***                   CBS 123127            GU456330                        GU456313       GU456355   \-             GU456270       Zhang et al. \[[@B89-biomolecules-10-00569]\]
  ***Zeloasperisporium hyphopodioides***         CBS 218.95            EU035442                        \-             \-         \-             \-             Crous et al. \[[@B90-biomolecules-10-00569]\]
  ***Zeloasperisporium siamense***               IFRDCC 2194           JQ036228                        JQ036223       \-         \-             \-             Mapook et. al. \[[@B73-biomolecules-10-00569]\]
  ***Zeloasperisporium wrightiae***              MFLUCC 15-0225        KT387737                        KT387738       \-         \-             \-             Hongsanan et al. \[[@B91-biomolecules-10-00569]\]

^1^ AFTOL-ID: Assembling the Fungal Tree of Life; BCC: BIOTEC Culture Collection; BRIP: Biosecurity Queensland Plant Pathology Herbarium, Brisbane, Australia; CBS: Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands; CCFEE: Culture Collection of Fungi from Extreme Environments, The University of Tuscia; CPC: Culture collection of Pedro Crous, the Netherlands; FMR: Facultad de Medicina, Reus, Tarragona, Spain; GZCC: Guizhou Culture Collection; IFRDCC = International Fungal Research and Development Centre Culture Collection, China; IMI: The International Mycological Institute Culture Collections; JK: J. Kohlmeyer; MFLU: the Herbarium of Mae Fah Luang University; MFLUCC: Mae Fah Luang University Culture Collection, Chiang Rai, Thailand; MUCL: Belgian Coordinated Collections of Microorganisms; URM: Universidade Federal de Pernambuco. ^2^ LSU: 28S large subunit of the nrRNA gene; SSU: 18S small subunit of the nrRNA gene; RPB2: partial RNA polymerase II second largest subunit gene; ITS: internal transcribed spacer regions 1 and 2 including 5.8S nrRNA gene; TEF1: partial translation elongation factor 1-α gene.
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###### 

NMR spectroscopic data for pseudopalawanone (**1**).

  No.    *δ~H~*, m, *J* (Hz)     *δ~C~*, m     No.      *δ~H~*, m, *J* (Hz)    *δ~C~*, m
  ------ ----------------------- ------------- -------- ---------------------- -------------
  1      \-                      160.1, C      1′       \-                     161.8, C
  2      \-                      117.6, C      2′       6.66, d (8.7)          110.4, CH
  3      7.82, d (8.6)           143.8, CH     3′       7.54, d (8.7)          141.2, CH
  4      6.77, d (8.6)           108.3, CH     4′       \-                     114.0, C
  4a     \-                      158.3, C      4a′      \-                     155.6, C
  5      4.44, d (4.0)           74.1, CH      5′       4.38, d (2.5)          88.1, CH
  6      2.13, m                 30.4, CH      6′       2.65, m                29.9, CH
  7*a*   2.36, dd (15.9, 13.6)   33.8, CH~2~   7′*a*    2.18, m                35.8, CH~2~
  *b*    2.12, m                               *b*      1.99, dd (18.3, 3.1)   
  8      \-                      108.9, C      8′       \-                     176.5, C
  8a     \-                      73.6, C       8a′*a*   3.14, d (16.9)         39.6, CH~2~
                                               *b*      2.98, d (16.9)         
  9      \-                      194.9, C      9′       \-                     193.6, C
  9a     \-                      106.8, C      9a′      \-                     107.6, C
  10a    \-                      84.7, C       10a′     \-                     84.8, C
  11     1.20, d (6.5)           14.9, CH~3~   11′      1.16, d (7.2)          20.9, CH~3~
  12     \-                      176.6, C      12′      \-                     168.5, C
  13     \-                      \-            13′      3.80, s                53.7, CH~3~
  1-OH   11.35, s                \-            1′-OH    11.51, s               \-
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###### 

Antimicrobial activity of compounds **1**--**5**.

  Tested Organisms              Strain No.    Minimum Inhibitory Concentration (MIC) \[μg/mL\]                           
  ----------------------------- ------------- -------------------------------------------------- ------ ------ ---- ---- ----------------
  ***Fungi***                                                                                                            
  *Candida albicans*            DSM 1665      \-                                                 66.7   \-     \-   \-   66.7 (20 µL N)
  *Cryptococcus neoformans*     DSM 15466     \-                                                 \-     \-     \-   \-   66.7 (20 µL N)
  *Mucor hiemalis*              DSM 6766      \-                                                 \-     66.7   \-   \-   66.7 (20 µL N)
  *Pichia anomala*              DSM 6766      \-                                                 \-     \-     \-   \-   66.7 (20 µL N)
  *Rhodoturula glutinis*        DSM 10134     \-                                                 \-     \-     \-   \-   16.7 (20 µL N)
  *Schizosaccharomyces pombe*   DSM 70572     \-                                                 \-     \-     \-   \-   33.3 (20 µL N)
  ***Bacteria***                                                                                                         
  *Bacillus subtilis*           DSM 10        66.7                                               1.0    4.2    \-   \-   8.3 (20 µL O)
  *Chromobacterium violaceum*   DSM 30191     \-                                                 \-     \-     \-   \-   1.7 (2 µL O)
  *Escherichia coli*            DSM 1116      \-                                                 \-     \-     \-   \-   3.3 (2 µL O)
  *Micrococcus luteus*          DSM 1790      66.7                                               8.3    33.3   \-   \-   0.4 (2 µL O)
  *Mycobacterium smegmatis*     ATCC 700084   \-                                                 66.7   \-     \-   \-   3.3 (2 µL K)
  *Pseudomonas aeruginosa*      PA14          \-                                                 \-     \-     \-   \-   0.8 (2 µL G)
  *Staphylococcus aureus*       DSM 346       66.7                                               4.2    33.3   \-   \-   0.2 (2 µL O)

\* Positive drug controls: K = kanamycin, N = nystatin, O = oxytetracycline hydrochloride. (-): no inhibition. The starting concentration was 66.7 µg/mL.
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###### 

Cytotoxic activity of compounds **1**--**5**.

  Cell Lines                IC~50~ (µM)                           
  ------------------------- ------------- ------ ------ ---- ---- --------------
  *HeLa cells KB3.1*        29.7          3.9    17.2   \-   \-   8.9 × 10^−5^
  *Mouse fibroblast L929*   50.0          14.1   \-     \-   \-   1.8 × 10^−3^

The *in vitro* cytotoxicity test of polyketides **1**--**5** was conducted against two mammalian cell lines, with epothilone B as positive control. Starting concentration for cytotoxicity assay was 66 μg/mL, substances were dissolved in MeOH (1 mg/mL). MeOH was used as negative control and showed no activity against the tested mammalian cell lines. Results were expressed as IC~50~: half maximal inhibitory concentration (µM). (-): no inhibition.

[^1]: These authors contributed equally to this work.
